Companies/Models & infrastructure/Independent research

Aitia

aitia.com1 articleIndependent coverage

In the sequence

Published research

Bblueprint

Aitia uses causal AI to turn human disease data into testable drug hypotheses

Aitia’s Gemini Digital Twins explained: disease models, target discovery, drug simulation and publicly disclosed collaboration terms.

Models & infrastructureThu, 29 Oct 2026

7 minread

Also in this category

All in Models & infrastructure

AbCelleraabcellera.comprofiled

Absciabsci.comprofiled

Aceracer.comprofiled

Explore related research and compare the fit for your work.

Aitia

Independent company blueprint. Not affiliated with or approved by the company.

Suggest a correction →

For this company

Contribute evidence or request a correction without an account. Verify your work email to save contributions, request research and follow your requests in a private workspace. Paid services are coming soon.

For companies →